Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies

[1]  J. Green,et al.  Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies , 2007, International journal of cancer.

[2]  Joakim Dillner,et al.  Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies , 2006, International journal of cancer.

[3]  V. Beral,et al.  Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies , 2006, International journal of cancer.

[4]  K. Straif,et al.  Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. , 2005, The Lancet. Oncology.

[5]  S. Franceschi,et al.  Cervical carcinoma in Algiers, Algeria: Human papillomavirus and lifestyle risk factors , 2005, International journal of cancer.

[6]  F. Bray,et al.  Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost , 2004, International journal of cancer.

[7]  M. Plummer.  Improved estimates of floating absolute risk , 2004, Statistics in medicine.

[8]  M P Vessey,et al.  Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case–Control Study of Cervical Cancer , 2003, British Journal of Cancer.

[9]  S. Franceschi,et al.  Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case‐control study , 2003, International journal of cancer.

[10]  Valerie Beral,et al.  Breast cancer and hormone-replacement therapy in the Million Women Study , 2003, The Lancet.

[11]  S. Shapiro,et al.  Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) , 2003, Cancer Causes & Control.

[12]  M. Schiffman,et al.  Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. , 2003, Journal of the National Cancer Institute. Monographs.

[13]  V. Beral,et al.  Cervical cancer and use of hormonal contraceptives: a systematic review , 2003, The Lancet.

[14]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[15]  P. Coursaget,et al.  Risk factors of invasive cervical cancer in Mali. , 2002, International journal of epidemiology.

[16]  N. Muñoz,et al.  HPV types and cofactors causing cervical cancer in Peru , 2001, British Journal of Cancer.

[17]  S. Wacholder,et al.  HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica , 2001, British Journal of Cancer.

[18]  N. Kiviat,et al.  Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. , 2001, American journal of epidemiology.

[19]  J. Peto,et al.  Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort , 2000, British Journal of Cancer.

[20]  V. Beral,et al.  The spectrum of HIV‐1 related cancers in South Africa , 2000, International journal of cancer.

[21]  N. Muñoz,et al.  Human papillomavirus infection and invasive cervical cancer in Paraguay , 2000, International journal of cancer.

[22]  H. Adami,et al.  Smoking and oral contraceptives as risk factors for cervical carcinoma In situ , 1999, International journal of cancer.

[23]  C. la Vecchia,et al.  Time since last use of oral contraceptives and risk of invasive cervical cancer. , 1998, European journal of cancer.

[24]  N. Muñoz,et al.  The viral origin of cervical cancer in Rabat, Morocco , 1998, International journal of cancer.

[25]  F. X. Bosch,et al.  Causes of cervical cancer in the Philippines: a case-control study. , 1998, Journal of the National Cancer Institute.

[26]  F. X. Bosch,et al.  Risk factors for cervical cancer in Thailand: a case-control study. , 1998, Journal of the National Cancer Institute.

[27]  R. Ray,et al.  Oral Contraceptives and Invasive Adenocarcinomas and Adenosquamous Carcinomas of the Uterine Cervix , 1996 .

[28]  M. Pike,et al.  Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States) , 1996, Cancer Causes & Control.

[29]  K. Zondervan,et al.  Oral contraceptives and cervical cancer--further findings from the Oxford Family Planning Association contraceptive study. , 1996, British Journal of Cancer.

[30]  J. Cuzick,et al.  Risk factors for invasive cervix cancer in young women. , 1996, European journal of cancer.

[31]  M. Sherman,et al.  Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia , 1996 .

[32]  D. Thomas,et al.  Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1995, Contraception.

[33]  L. Kuller,et al.  Refining Preventive Strategies for Invasive Cervical Cancer: A Population-Based Case-Control Study , 1995 .

[34]  D. Thomas,et al.  Combined oral contraceptives and risk of cervical carcinoma in situ. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1995, International journal of epidemiology.

[35]  M. Pike,et al.  Oral contraceptive use and adenocarcinoma of cervix , 1994, The Lancet.

[36]  F. X. Bosch,et al.  Human papillomavirus and invasive cervical cancer in Brazil. , 1994, British Journal of Cancer.

[37]  S. Kjaer,et al.  Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use , 1993, Cancer Causes & Control.

[38]  B. Modan,et al.  Invasive squamous‐cell cervical carcinoma and combined oral contraceptives: Results from a multinational study , 1993 .

[39]  S Wacholder,et al.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. , 1993, Journal of the National Cancer Institute.

[40]  J. Kaldor,et al.  Risk factors for cervical cancer in Colombia and Spain , 1992, International journal of cancer.

[41]  I. Gram,et al.  Oral contraceptive use and the incidence of cervical intraepithelial neoplasia. , 1992, American journal of obstetrics and gynecology.

[42]  E. Negri,et al.  Risk factors for cervical intraepithelial neoplasia , 1992, Cancer.

[43]  L. Brinton,et al.  Injectable contraceptives and risk of invasive cervical cancer: Evidence of an association , 1990, International journal of cancer.

[44]  L. Brinton,et al.  Oral contraceptive use and risk of invasive cervical cancer. , 1990, International journal of epidemiology.

[45]  Valerie Beral,et al.  ORAL CONTRACEPTIVE USE AND MALIGNANCIES OF THE GENITAL TRACT Results from The Royal College of General Practitioners' Oral Contraception Study , 1988, The Lancet.

[46]  C. la Vecchia,et al.  Risk factors for adenocarcinoma of the cervix: a case-control study. , 1988, British Journal of Cancer.

[47]  K. Ebeling,et al.  Use of oral contraceptives and risk of invasive cervical cancer in previously screened women , 1987, International journal of cancer.

[48]  D. Savitz,et al.  Long‐term use of oral contraceptives and risk of invasive cervical cancer , 1986, International journal of cancer.

[49]  R. Fruchter,et al.  Oral contraceptives and cervical carcinoma. , 1977, American journal of obstetrics and gynecology.

[50]  D. Boyes,et al.  A CASE CONTROL STUDY INTO THE POSSIBLE EFFECTS OF BIRTH CONTROL PILLS ON PRE‐CLINICAL CARCINOMA OF THE CERVIX , 1972, The Journal of obstetrics and gynaecology of the British Commonwealth.

[51]  M. Melamed,et al.  Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids* , 1969, British medical journal.

[52]  D. Thomas,et al.  Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1995, Contraception.

[53]  J. Cuzick,et al.  Case-control study of risk factors for cervical intraepithelial neoplasia in young women. , 1990, European journal of cancer.

[54]  J. Fortney,et al.  Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association? , 1988, JAMA.